Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular disease
MedTech
Boston Scientific pulls Acurate TAVR implants from market
It’s yet another setback for the company’s plans to break into the TAVR market, after it shuttered its Lotus Edge program in late 2020.
Conor Hale
May 28, 2025 11:01am
Abbott snags US approval for mitral valve replacement implant
May 27, 2025 10:30am
Philips to test ultralow-dose X-ray technique in cath lab study
May 20, 2025 2:30pm
J&J trials IVL-first strategy in women with blocked coronaries
May 20, 2025 11:45am
Former Pfizer antibody reduces cardio risk marker in ph. 2
May 20, 2025 7:30am
Element Science’s wearable defibrillator patch wins FDA approval
May 5, 2025 11:09am
